The NIH ME/CFS Conference II: Lipkin’s Possibilities, Prusty’s Big Idea, Oh’s Search and Ron Davis on ALWAYS Moving Forward
Day two of the Conference – not all of which is covered here, started off with a physicians’ panel, then NIH Director Francis Collins showed up (covered later) just before the Intramural study presented some results, then it was onto Ian Lipkin, Dr. Oh,...
From Hard Charging Executive to Bed Bound and (Almost) Back Again: An ME/CFS/FM Healing Story
I was a 29-year-old career woman who had been burning the candle at both ends for as long as I can remember. I had a high-powered job that required weekly travel, both nationally and internationally, consulting for executive management teams in Fortune 500 companies...
Death in Chronic Fatigue Syndrome (ME/CFS) – What has it Told Us? The Autopsy Files
It’s always hard to lose a loved one, but the deaths in ME/CFS seem particularly hard. They tend to be quite painful, they often take place in the midst of a non-supportive medical system, and they’re a complete mystery. With no seeming way out it’s...
Ramsay’s Continue Focus on the Mitochondria in ME/CFS – Plus, the Hunt for a Drug Target is On (!)
The Solve ME/CFS Initiative’s Ramsay Awards are small grants (@$50K – only in the medical field is 50K small) but potentially mighty grants. They are designed to give researchers the funding to produce pilot data needed to get really big grants – the...
Jarred Younger III : Treatments – A Better LDN and the Hunt for Microglia Inhibitors
Younger is studying a potentially more effective and side-effect free form of low dose naltrexone called dextro naltrexone. His botanicals study containing 9 plant compounds including resveratrol and cucurmin has wrapped up as well.Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
